O	O	O	0	9	Molecular	Molecular	B-NP	JJ	O	4	NMOD	O
O	O	O	10	13	and	and	I-NP	CC	O	4	NMOD	O
O	O	O	14	22	cellular	cellular	I-NP	JJ	O	4	NMOD	O
O	O	O	23	31	analysis	analysis	I-NP	NN	O	0	ROOT	O
O	O	O	32	34	of	of	B-PP	IN	O	4	NMOD	O
O	O	O	35	40	human	human	B-NP	JJ	O	8	NMOD	O
O	O	O	41	57	immunodeficiency	immunodeficiency	I-NP	NN	O	8	NMOD	O
O	O	O	58	63	virus	virus	I-NP	NN	O	11	NMOD	O
O	O	O	63	64	-	-	B-NP	HYPH	O	11	NMOD	O
O	O	O	64	71	induced	induce	I-NP	VBN	O	11	NMOD	O
O	O	O	72	81	apoptosis	apoptosis	I-NP	NN	O	5	PMOD	O
O	O	O	82	84	in	in	B-PP	IN	O	11	NMOD	O
O	O	O	85	99	lymphoblastoid	lymphoblastoid	B-NP	JJ	B-cell_line	18	NMOD	B-cell_line
O	O	O	100	101	T	T	I-NP	NN	I-cell_line	18	NMOD	I-cell_line
O	O	O	101	102	-	-	B-NP	HYPH	I-cell_line	18	P	I-cell_line
O	O	O	102	106	cell	cell	I-NP	NN	I-cell_line	18	NMOD	I-cell_line
O	O	O	106	107	-	-	B-NP	HYPH	I-cell_line	18	P	I-cell_line
O	O	O	107	111	line	line	I-NP	NN	I-cell_line	12	PMOD	I-cell_line
O	O	O	111	112	-	-	O	HYPH	O	18	P	O
O	O	O	112	122	expressing	express	B-VP	VBG	O	18	NMOD	O
O	O	O	123	127	wild	wild	B-NP	JJ	B-protein	27	NMOD	B-protein
O	O	O	127	128	-	-	I-NP	HYPH	I-protein	27	NMOD	I-protein
O	O	O	128	132	type	type	I-NP	NN	I-protein	27	NMOD	I-protein
O	O	O	133	136	and	and	O	CC	I-protein	27	NMOD	I-protein
O	O	O	137	144	mutated	mutate	B-NP	VBN	I-protein	27	NMOD	I-protein
T1	B-Protein	B-Protein	145	148	CD4	CD4	I-NP	NN	I-protein	27	NMOD	I-protein
T1	I-Protein	I-Protein	149	158	receptors	receptor	I-NP	NNS	I-protein	20	OBJ	I-protein
O	O	O	158	159	.	.	O	.	O	4	P	O

O	O	O	161	163	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	164	168	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	169	179	previously	previously	I-VP	RB	O	2	VMOD	O
O	O	O	180	185	shown	show	I-VP	VBN	O	2	VC	O
O	O	O	186	190	that	that	B-SBAR	IN	O	4	VMOD	O
O	O	O	191	194	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	195	203	presence	presence	I-NP	NN	O	13	SUB	O
O	O	O	204	206	of	of	B-PP	IN	O	7	NMOD	O
O	O	O	207	210	the	the	B-NP	DT	O	12	NMOD	O
T2	B-Protein	B-Protein	211	214	CD4	CD4	I-NP	NN	B-protein	12	NMOD	B-protein
T19	B-Entity	B-Entity	215	226	cytoplasmic	cytoplasmic	I-NP	JJ	I-protein	12	NMOD	I-protein
T19	I-Entity	I-Entity	227	231	tail	tail	I-NP	NN	I-protein	8	PMOD	I-protein
O	O	O	232	234	is	be	B-VP	VBZ	O	5	SBAR	O
O	O	O	235	243	critical	critical	B-ADJP	JJ	O	13	PRD	O
O	O	O	244	247	for	for	B-PP	IN	O	14	AMOD	O
O	O	O	248	253	human	human	B-NP	JJ	O	18	NMOD	O
O	O	O	254	270	immunodeficiency	immunodeficiency	I-NP	NN	O	18	NMOD	O
O	O	O	271	276	virus	virus	I-NP	NN	O	24	NMOD	O
O	O	O	277	278	(	(	O	(	O	21	DEP	O
O	O	O	278	281	HIV	HIV	B-NP	NN	O	21	DEP	O
O	O	O	281	282	)	)	O	)	O	18	NMOD	O
O	O	O	282	283	-	-	B-NP	HYPH	O	18	NMOD	O
O	O	O	283	290	induced	induce	I-NP	VBN	O	24	NMOD	O
O	O	O	291	300	apoptosis	apoptosis	I-NP	NN	O	15	PMOD	O
O	O	O	301	302	(	(	O	(	O	54	DEP	O
O	O	O	302	303	J	J	B-NP	NNP	O	28	NMOD	O
O	O	O	303	304	.	.	I-NP	.	O	28	P	O
O	O	O	304	311	Corbeil	Corbeil	I-NP	NNP	O	39	NMOD	O
O	O	O	311	312	,	,	O	,	O	39	P	O
O	O	O	313	314	M	M	B-NP	NNP	O	32	NMOD	O
O	O	O	314	315	.	.	I-NP	.	O	32	P	O
O	O	O	315	323	Tremblay	Tremblay	I-NP	NNP	O	39	NMOD	O
O	O	O	323	324	,	,	O	,	O	39	P	O
O	O	O	325	328	and	and	O	CC	O	39	NMOD	O
O	O	O	329	330	D	D	B-NP	NNP	O	37	NMOD	O
O	O	O	330	331	.	.	I-NP	.	O	37	P	O
O	O	O	331	332	D	D	I-NP	NNP	O	39	NMOD	O
O	O	O	332	333	.	.	I-NP	.	O	39	P	O
O	O	O	333	340	Richman	Richman	I-NP	NNP	O	53	NMOD	O
O	O	O	340	341	,	,	O	,	O	53	P	O
O	O	O	342	343	J	J	B-NP	NNP	O	43	NMOD	O
O	O	O	343	344	.	.	I-NP	.	O	43	P	O
O	O	O	344	347	Exp	Exp	I-NP	NNP	O	45	NMOD	O
O	O	O	347	348	.	.	I-NP	.	O	45	P	O
O	O	O	348	351	Med	Med	I-NP	NNP	O	53	NMOD	O
O	O	O	351	352	.	.	I-NP	.	O	53	P	O
O	O	O	352	355	183	183	I-NP	CD	O	51	NMOD	O
O	O	O	355	356	:	:	O	:	O	51	P	O
O	O	O	356	358	39	39	B-NP	CD	O	51	AMOD	O
O	O	O	358	359	-	-	I-NP	HYPH	O	51	P	O
O	O	O	359	361	48	48	I-NP	CD	O	53	NMOD	O
O	O	O	361	362	,	,	I-NP	,	O	53	P	O
O	O	O	363	367	1996	1996	I-NP	CD	O	54	DEP	O
O	O	O	367	368	)	)	O	)	O	24	NMOD	O
O	O	O	368	369	.	.	O	.	O	2	P	O

O	O	O	370	372	We	We	B-NP	PRP	O	2	SUB	O
O	O	O	373	377	have	have	B-VP	VBP	O	0	ROOT	O
O	O	O	378	385	pursued	pursue	I-VP	VBN	O	2	VC	O
O	O	O	386	389	our	our	B-NP	PRP$	O	5	NMOD	O
O	O	O	390	403	investigation	investigation	I-NP	NN	O	3	OBJ	O
O	O	O	404	406	of	of	B-PP	IN	O	5	NMOD	O
O	O	O	407	410	the	the	B-NP	DT	O	8	NMOD	O
O	O	O	411	415	role	role	I-NP	NN	O	6	PMOD	O
O	O	O	416	418	of	of	B-PP	IN	O	8	NMOD	O
O	O	O	419	422	the	the	B-NP	DT	O	13	NMOD	O
T3	B-Protein	B-Protein	423	426	CD4	CD4	I-NP	NN	B-protein	13	NMOD	B-protein
O	O	O	427	439	transduction	transduction	I-NP	NN	O	13	NMOD	O
O	O	O	440	447	pathway	pathway	I-NP	NN	O	9	PMOD	O
O	O	O	448	450	in	in	B-PP	IN	O	8	NMOD	O
O	O	O	451	454	HIV	HIV	B-NP	NN	O	18	NMOD	O
O	O	O	454	455	-	-	B-NP	HYPH	O	18	NMOD	O
O	O	O	455	462	induced	induce	I-NP	VBN	O	18	NMOD	O
O	O	O	463	472	apoptosis	apoptosis	I-NP	NN	O	14	PMOD	O
O	O	O	472	473	.	.	O	.	O	2	P	O

O	O	O	474	476	To	To	B-VP	TO	O	2	VMOD	O
O	O	O	477	479	do	do	I-VP	VB	O	16	VMOD	O
O	O	O	480	484	this	this	B-NP	DT	O	2	OBJ	O
O	O	O	484	485	,	,	O	,	O	16	P	O
T20	B-Entity	B-Entity	486	490	wild	wild	B-NP	JJ	O	10	NMOD	O
T20	I-Entity	I-Entity	490	491	-	-	I-NP	HYPH	O	10	P	O
T20	I-Entity	I-Entity	491	495	type	type	I-NP	NN	O	10	NMOD	O
O	O	O	496	499	and	and	I-NP	CC	O	10	NMOD	O
T21	B-Entity	B-Entity	500	506	mutant	mutant	I-NP	JJ	O	10	NMOD	O
T21	I-Entity	I-Entity	507	512	forms	form	I-NP	NNS	O	16	SUB	O
O	O	O	513	515	of	of	B-PP	IN	O	10	NMOD	O
O	O	O	516	519	the	the	B-NP	DT	O	15	NMOD	O
T4	B-Protein	B-Protein	520	523	CD4	CD4	I-NP	NN	B-protein	15	NMOD	B-protein
T22	B-Entity	B-Entity	524	535	cytoplasmic	cytoplasmic	I-NP	JJ	I-protein	15	NMOD	I-protein
T22	I-Entity	I-Entity	536	540	tail	tail	I-NP	NN	I-protein	11	PMOD	I-protein
O	O	O	541	545	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	546	552	stably	stably	I-VP	RB	O	16	VMOD	O
O	O	O	553	562	expressed	express	I-VP	VBN	O	16	VC	O
O	O	O	563	565	in	in	B-PP	IN	O	18	VMOD	O
O	O	O	566	569	the	the	B-NP	DT	O	26	NMOD	O
O	O	O	570	584	lymphoblastoid	lymphoblastoid	I-NP	JJ	B-cell_line	25	NMOD	B-cell_line
O	O	O	585	586	T	T	I-NP	NN	I-cell_line	25	NMOD	I-cell_line
O	O	O	586	587	-	-	I-NP	HYPH	I-cell_line	25	P	I-cell_line
O	O	O	587	591	cell	cell	I-NP	NN	I-cell_line	25	NMOD	I-cell_line
O	O	O	592	596	line	line	I-NP	NN	I-cell_line	26	NMOD	I-cell_line
O	O	O	597	599	A2	A2	I-NP	NN	O	19	PMOD	O
O	O	O	599	600	.	.	O	.	O	16	P	O
O	O	O	600	602	01	01	B-NP	CD	O	16	VMOD	O
O	O	O	602	603	.	.	O	.	O	16	P	O

O	O	O	604	613	Apoptosis	Apoptosis	B-NP	NN	O	2	SUB	O
O	O	O	614	617	was	be	B-VP	VBD	O	49	VMOD	O
O	O	O	618	627	prevented	prevent	I-VP	VBN	O	2	VC	O
O	O	O	628	632	when	when	B-ADVP	WRB	O	3	VMOD	O
T5	B-Protein	B-Protein	633	636	CD4	CD4	B-NP	NN	B-protein	10	SUB	B-protein
O	O	O	637	646	truncated	truncate	B-VP	VBN	O	5	NMOD	O
O	O	O	647	649	at	at	B-PP	IN	O	6	VMOD	O
T23	B-Entity	B-Entity	650	657	residue	residue	B-NP	NN	O	7	PMOD	O
T23	I-Entity	I-Entity	658	661	402	402	I-NP	CD	O	8	NMOD	O
O	O	O	662	665	was	be	B-VP	VBD	O	4	SBAR	O
O	O	O	666	675	expressed	express	I-VP	VBN	O	10	VC	O
O	O	O	675	676	;	;	O	:	O	49	P	O
O	O	O	677	684	however	however	B-ADVP	RB	O	49	VMOD	O
O	O	O	684	685	,	,	O	,	O	49	P	O
O	O	O	686	691	cells	cell	B-NP	NNS	O	49	SUB	O
O	O	O	692	702	expressing	express	B-VP	VBG	O	15	NMOD	O
O	O	O	703	710	mutated	mutate	B-NP	VBN	B-protein	18	NMOD	B-protein
O	O	O	711	720	receptors	receptor	I-NP	NNS	I-protein	16	OBJ	I-protein
O	O	O	721	725	that	that	B-NP	WDT	O	41	DEP	O
O	O	O	726	728	do	do	B-VP	VBP	O	19	SBAR	O
O	O	O	729	732	not	not	I-VP	RB	O	20	VMOD	O
O	O	O	733	742	associate	associate	I-VP	VB	O	20	VC	O
O	O	O	743	747	with	with	B-PP	IN	O	22	VMOD	O
T6	B-Protein	B-Protein	748	751	p56	p56	B-NP	NN	B-protein	26	NMOD	B-protein
T6	I-Protein	I-Protein	751	752	(	(	O	(	I-protein	26	NMOD	I-protein
T6	I-Protein	I-Protein	752	755	lck	lck	B-NP	NN	I-protein	23	PMOD	I-protein
T6	I-Protein	I-Protein	755	756	)	)	O	)	I-protein	26	NMOD	I-protein
O	O	O	757	758	(	(	O	(	O	39	DEP	O
O	O	O	758	765	mutated	mutate	B-VP	VBN	O	39	DEP	O
O	O	O	766	768	at	at	B-PP	IN	O	29	VMOD	O
O	O	O	769	772	the	the	B-NP	DT	O	33	NMOD	O
O	O	O	773	783	dicysteine	dicysteine	I-NP	NN	B-protein	33	NMOD	B-protein
O	O	O	784	789	motif	motif	I-NP	NN	I-protein	30	PMOD	I-protein
O	O	O	790	793	and	and	O	CC	O	29	VMOD	O
O	O	O	794	803	truncated	truncate	B-VP	VBN	O	29	VMOD	O
O	O	O	804	806	at	at	B-PP	IN	O	35	VMOD	O
T24	B-Entity	B-Entity	807	814	residue	residue	B-NP	NN	O	36	PMOD	O
T24	I-Entity	I-Entity	815	818	418	418	I-NP	CD	O	37	NMOD	O
O	O	O	818	819	)	)	O	)	O	26	NMOD	O
O	O	O	820	823	but	but	O	CC	O	41	DEP	O
O	O	O	824	829	which	which	B-NP	WDT	O	18	NMOD	O
O	O	O	830	839	conserved	conserve	B-VP	VBD	O	41	SBAR	O
O	O	O	840	848	proximal	proximal	B-NP	JJ	B-protein	44	NMOD	B-protein
O	O	O	849	856	domains	domain	I-NP	NNS	I-protein	42	OBJ	I-protein
O	O	O	857	859	of	of	B-PP	IN	O	44	NMOD	O
O	O	O	860	863	the	the	B-NP	DT	O	48	NMOD	O
T25	B-Entity	B-Entity	864	875	cytoplasmic	cytoplasmic	I-NP	JJ	B-protein	48	NMOD	B-protein
T25	I-Entity	I-Entity	876	880	tail	tail	I-NP	NN	I-protein	45	PMOD	I-protein
O	O	O	881	890	underwent	undergo	B-VP	VBD	O	0	ROOT	O
O	O	O	891	900	apoptosis	apoptosis	B-NP	NN	O	49	OBJ	O
O	O	O	901	905	like	like	B-PP	IN	O	49	VMOD	O
O	O	O	906	910	wild	wild	B-NP	JJ	B-protein	55	NMOD	B-protein
O	O	O	910	911	-	-	I-NP	HYPH	I-protein	55	NMOD	I-protein
O	O	O	912	916	type	type	I-NP	NN	I-protein	55	NMOD	I-protein
T7	B-Protein	B-Protein	917	920	CD4	CD4	I-NP	NN	I-protein	51	PMOD	I-protein
O	O	O	920	921	.	.	O	.	O	49	P	O

O	O	O	922	925	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	926	937	differences	difference	I-NP	NNS	O	15	SUB	O
O	O	O	938	945	between	between	B-PP	IN	O	2	NMOD	O
O	O	O	946	950	wild	wild	B-NP	JJ	B-protein	9	NMOD	B-protein
O	O	O	950	951	-	-	I-NP	HYPH	I-protein	9	P	I-protein
O	O	O	951	955	type	type	I-NP	NN	I-protein	9	NMOD	I-protein
O	O	O	956	959	and	and	O	CC	I-protein	9	NMOD	I-protein
O	O	O	960	967	mutated	mutate	B-NP	VBN	I-protein	9	NMOD	I-protein
O	O	O	968	977	receptors	receptor	I-NP	NNS	I-protein	3	PMOD	I-protein
O	O	O	978	980	in	in	B-PP	IN	O	9	NMOD	O
O	O	O	981	984	the	the	B-NP	DT	O	12	NMOD	O
O	O	O	985	994	induction	induction	I-NP	NN	O	10	PMOD	O
O	O	O	995	997	of	of	B-PP	IN	O	12	NMOD	O
O	O	O	998	1007	apoptosis	apoptosis	B-NP	NN	O	13	PMOD	O
O	O	O	1008	1012	were	be	B-VP	VBD	O	0	ROOT	O
O	O	O	1013	1016	not	not	O	RB	O	15	VMOD	O
O	O	O	1017	1024	related	related	B-ADJP	JJ	O	15	PRD	O
O	O	O	1025	1027	to	to	B-PP	TO	O	17	AMOD	O
O	O	O	1028	1034	levels	level	B-NP	NNS	O	18	PMOD	O
O	O	O	1035	1037	of	of	B-PP	IN	O	19	NMOD	O
T8	B-Protein	B-Protein	1038	1041	p56	p56	B-NP	NN	B-protein	23	NMOD	B-protein
T8	I-Protein	I-Protein	1041	1042	(	(	O	(	I-protein	23	NMOD	I-protein
T8	I-Protein	I-Protein	1042	1045	lck	lck	B-NP	NN	I-protein	29	NMOD	I-protein
T8	I-Protein	I-Protein	1045	1046	)	)	O	)	I-protein	23	NMOD	I-protein
O	O	O	1047	1049	or	or	O	CC	O	29	NMOD	O
T26	B-Entity	B-Entity	1050	1052	NF	NF	B-NP	NN	B-protein	28	NMOD	B-protein
T26	I-Entity	I-Entity	1052	1053	-	-	B-NP	HYPH	I-protein	28	NMOD	I-protein
T26	I-Entity	I-Entity	1054	1060	kappaB	kappaB	I-NP	NN	I-protein	29	NMOD	I-protein
O	O	O	1061	1071	activation	activation	I-NP	NN	O	20	PMOD	O
O	O	O	1071	1072	.	.	O	.	O	15	P	O

O	O	O	1073	1080	Initial	Initial	B-NP	JJ	O	2	NMOD	O
O	O	O	1081	1090	signaling	signaling	I-NP	NN	O	7	SUB	O
O	O	O	1091	1098	through	through	B-PP	IN	O	2	NMOD	O
O	O	O	1099	1102	the	the	B-NP	DT	O	6	NMOD	O
T9	B-Protein	B-Protein	1103	1106	CD4	CD4	I-NP	NN	B-protein	6	NMOD	B-protein
T9	I-Protein	I-Protein	1107	1115	receptor	receptor	I-NP	NN	I-protein	3	PMOD	I-protein
O	O	O	1116	1122	played	play	B-VP	VBD	O	0	ROOT	O
O	O	O	1123	1124	a	a	B-NP	DT	O	10	NMOD	O
O	O	O	1125	1130	major	major	I-NP	JJ	O	10	NMOD	O
O	O	O	1131	1135	role	role	I-NP	NN	O	7	OBJ	O
O	O	O	1136	1138	in	in	B-PP	IN	O	7	VMOD	O
O	O	O	1139	1142	the	the	B-NP	DT	O	13	NMOD	O
O	O	O	1143	1156	sensitization	sensitization	I-NP	NN	O	11	PMOD	O
O	O	O	1157	1159	of	of	B-PP	IN	O	13	NMOD	O
O	O	O	1160	1163	HIV	HIV	B-NP	NN	B-cell_type	19	NMOD	B-cell_type
O	O	O	1163	1164	-	-	B-NP	HYPH	I-cell_type	19	P	I-cell_type
O	O	O	1164	1172	infected	infect	I-NP	VBN	I-cell_type	19	NMOD	I-cell_type
O	O	O	1173	1174	T	T	I-NP	NN	I-cell_type	19	NMOD	I-cell_type
O	O	O	1175	1180	cells	cell	I-NP	NNS	I-cell_type	14	PMOD	I-cell_type
O	O	O	1181	1183	to	to	B-VP	TO	O	21	VMOD	O
O	O	O	1184	1191	undergo	undergo	I-VP	VB	O	7	VMOD	O
O	O	O	1192	1201	apoptosis	apoptosis	B-NP	NN	O	21	OBJ	O
O	O	O	1201	1202	.	.	O	.	O	7	P	O

O	O	O	1203	1213	Incubation	Incubation	B-NP	NN	O	31	SUB	O
O	O	O	1214	1216	of	of	B-PP	IN	O	1	NMOD	O
O	O	O	1217	1220	HIV	HIV	B-NP	NN	B-cell_type	6	NMOD	B-cell_type
O	O	O	1220	1221	-	-	B-NP	HYPH	I-cell_type	6	NMOD	I-cell_type
O	O	O	1221	1229	infected	infect	I-NP	VBN	I-cell_type	6	NMOD	I-cell_type
O	O	O	1230	1235	cells	cell	I-NP	NNS	I-cell_type	2	PMOD	I-cell_type
O	O	O	1236	1240	with	with	B-PP	IN	O	1	NMOD	O
O	O	O	1241	1251	monoclonal	monoclonal	B-NP	JJ	B-protein	9	NMOD	B-protein
O	O	O	1252	1260	antibody	antibody	I-NP	NN	I-protein	7	PMOD	I-protein
O	O	O	1261	1262	(	(	O	(	O	12	DEP	O
O	O	O	1262	1265	MAb	MAb	B-NP	NN	B-protein	12	DEP	B-protein
O	O	O	1265	1266	)	)	O	)	O	9	NMOD	O
O	O	O	1267	1271	13B8	13B8	B-NP	CD	O	9	NMOD	O
O	O	O	1271	1272	-	-	I-NP	HYPH	O	9	P	O
O	O	O	1272	1273	2	2	I-NP	CD	O	9	NMOD	O
O	O	O	1273	1274	,	,	O	,	O	9	P	O
O	O	O	1275	1280	which	which	B-NP	WDT	O	9	NMOD	O
O	O	O	1281	1286	binds	bind	B-VP	VBZ	O	17	SBAR	O
O	O	O	1287	1289	to	to	B-PP	TO	O	18	VMOD	O
T10	B-Protein	B-Protein	1290	1293	CD4	CD4	B-NP	NN	B-protein	19	PMOD	B-protein
O	O	O	1294	1296	in	in	B-PP	IN	O	18	VMOD	O
O	O	O	1297	1298	a	a	B-NP	DT	O	23	NMOD	O
O	O	O	1299	1305	region	region	I-NP	NN	O	21	PMOD	O
O	O	O	1306	1314	critical	critical	B-ADJP	JJ	O	23	NMOD	O
O	O	O	1315	1318	for	for	B-PP	IN	O	24	AMOD	O
O	O	O	1319	1331	dimerization	dimerization	B-NP	NN	O	25	PMOD	O
O	O	O	1332	1334	of	of	B-PP	IN	O	26	NMOD	O
O	O	O	1335	1338	the	the	B-NP	DT	O	29	NMOD	O
O	O	O	1339	1347	receptor	receptor	I-NP	NN	O	27	PMOD	O
O	O	O	1347	1348	,	,	O	,	O	1	P	O
O	O	O	1349	1358	prevented	prevent	B-VP	VBD	O	0	ROOT	O
O	O	O	1359	1368	apoptosis	apoptosis	B-NP	NN	O	31	OBJ	O
O	O	O	1369	1376	without	without	B-PP	IN	O	31	VMOD	O
O	O	O	1377	1387	inhibiting	inhibit	B-VP	VBG	O	33	PMOD	O
O	O	O	1388	1391	HIV	HIV	B-NP	NN	O	36	NMOD	O
O	O	O	1392	1403	replication	replication	I-NP	NN	O	34	OBJ	O
O	O	O	1403	1404	.	.	O	.	O	31	P	O

O	O	O	1405	1413	Moreover	Moreover	B-ADVP	RB	O	6	VMOD	O
O	O	O	1413	1414	,	,	O	,	O	6	P	O
O	O	O	1415	1418	the	the	B-NP	DT	O	5	NMOD	O
O	O	O	1419	1428	apoptotic	apoptotic	I-NP	JJ	O	5	NMOD	O
O	O	O	1429	1436	process	process	I-NP	NN	O	6	SUB	O
O	O	O	1437	1440	was	be	B-VP	VBD	O	29	VMOD	O
O	O	O	1441	1444	not	not	O	RB	O	6	VMOD	O
O	O	O	1445	1452	related	related	B-ADJP	JJ	O	6	PRD	O
O	O	O	1453	1455	to	to	B-PP	TO	O	8	AMOD	O
T11	B-Protein	B-Protein	1456	1459	Fas	Fas	B-NP	NN	B-protein	14	NMOD	B-protein
O	O	O	1459	1460	-	-	I-NP	HYPH	O	14	NMOD	O
T12	B-Protein	B-Protein	1460	1463	Fas	Fas	I-NP	NN	B-protein	14	NMOD	B-protein
T12	I-Protein	I-Protein	1464	1470	ligand	ligand	I-NP	NN	I-protein	14	NMOD	I-protein
O	O	O	1471	1482	interaction	interaction	I-NP	NN	O	9	PMOD	O
O	O	O	1482	1483	;	;	O	:	O	6	P	O
O	O	O	1484	1491	however	however	B-ADVP	RB	O	29	VMOD	O
O	O	O	1491	1492	,	,	O	,	O	29	P	O
O	O	O	1493	1495	an	an	B-NP	DT	O	23	NMOD	O
O	O	O	1496	1508	antagonistic	antagonistic	I-NP	JJ	O	23	NMOD	O
O	O	O	1509	1513	anti	anti	I-NP	AFX	O	23	NMOD	O
O	O	O	1513	1514	-	-	I-NP	HYPH	O	23	NMOD	O
T13	B-Protein	B-Protein	1514	1517	Fas	Fas	I-NP	NN	B-protein	23	NMOD	B-protein
O	O	O	1518	1521	MAb	MAb	I-NP	NN	O	29	SUB	O
O	O	O	1522	1523	(	(	O	(	O	28	DEP	O
O	O	O	1523	1525	ZB	ZB	B-NP	NN	B-protein	27	NMOD	B-protein
O	O	O	1525	1526	-	-	B-NP	HYPH	O	27	P	O
O	O	O	1526	1527	4	4	I-NP	CD	O	28	DEP	O
O	O	O	1527	1528	)	)	O	)	O	23	NMOD	O
O	O	O	1529	1537	enhanced	enhance	B-VP	VBD	O	0	ROOT	O
O	O	O	1538	1547	apoptosis	apoptosis	B-NP	NN	O	29	OBJ	O
O	O	O	1548	1550	in	in	B-PP	IN	O	30	NMOD	O
O	O	O	1551	1554	HIV	HIV	B-NP	NN	B-cell_type	35	NMOD	B-cell_type
O	O	O	1554	1555	-	-	B-NP	HYPH	I-cell_type	35	NMOD	I-cell_type
O	O	O	1555	1563	infected	infect	I-NP	VBN	I-cell_type	35	NMOD	I-cell_type
O	O	O	1564	1569	cells	cell	I-NP	NNS	I-cell_type	31	PMOD	I-cell_type
O	O	O	1570	1577	without	without	B-PP	IN	O	29	VMOD	O
O	O	O	1578	1586	inducing	induce	B-VP	VBG	O	36	PMOD	O
O	O	O	1587	1596	apoptosis	apoptosis	B-NP	NN	O	37	OBJ	O
O	O	O	1597	1599	in	in	B-PP	IN	O	37	VMOD	O
O	O	O	1600	1610	uninfected	uninfected	B-NP	JJ	B-cell_type	41	NMOD	B-cell_type
O	O	O	1611	1616	cells	cell	I-NP	NNS	I-cell_type	39	PMOD	I-cell_type
O	O	O	1616	1617	.	.	O	.	O	29	P	O

O	O	O	1618	1623	These	These	B-NP	DT	O	2	NMOD	O
O	O	O	1624	1636	observations	observation	I-NP	NNS	O	3	SUB	O
O	O	O	1637	1648	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	O	1649	1653	that	that	B-SBAR	IN	O	3	VMOD	O
T14	B-Protein	B-Protein	1654	1657	CD4	CD4	B-NP	NN	B-protein	6	NMOD	B-protein
O	O	O	1658	1667	signaling	signaling	I-NP	NN	O	7	SUB	O
O	O	O	1668	1676	mediates	mediate	B-VP	VBZ	O	4	SBAR	O
O	O	O	1677	1680	HIV	HIV	B-NP	NN	O	11	NMOD	O
O	O	O	1680	1681	-	-	B-NP	HYPH	O	11	NMOD	O
O	O	O	1681	1688	induced	induce	I-NP	VBN	O	11	NMOD	O
O	O	O	1689	1698	apoptosis	apoptosis	I-NP	NN	O	7	OBJ	O
O	O	O	1699	1701	by	by	B-PP	IN	O	7	VMOD	O
O	O	O	1702	1703	a	a	B-NP	DT	O	14	NMOD	O
O	O	O	1704	1713	mechanism	mechanism	I-NP	NN	O	12	PMOD	O
O	O	O	1714	1725	independent	independent	B-ADJP	JJ	O	14	NMOD	O
O	O	O	1726	1728	of	of	B-PP	IN	O	15	AMOD	O
T15	B-Protein	B-Protein	1729	1732	Fas	Fas	B-NP	NN	B-protein	21	NMOD	B-protein
O	O	O	1732	1733	-	-	B-NP	HYPH	O	21	P	O
T16	B-Protein	B-Protein	1733	1736	Fas	Fas	I-NP	NN	B-protein	21	NMOD	B-protein
T16	I-Protein	I-Protein	1737	1743	ligand	ligand	I-NP	NN	I-protein	21	NMOD	I-protein
O	O	O	1744	1755	interaction	interaction	I-NP	NN	O	16	PMOD	O
O	O	O	1755	1756	,	,	O	,	O	7	P	O
O	O	O	1757	1761	does	do	B-VP	VBZ	O	7	VMOD	O
O	O	O	1762	1765	not	not	I-VP	RB	O	23	VMOD	O
O	O	O	1766	1773	require	require	I-VP	VB	O	23	VC	O
T17	B-Protein	B-Protein	1774	1777	p56	p56	B-NP	NN	B-protein	28	NMOD	B-protein
T17	I-Protein	I-Protein	1777	1778	(	(	O	(	I-protein	28	NMOD	I-protein
T17	I-Protein	I-Protein	1778	1781	lck	lck	B-NP	NN	I-protein	30	NMOD	I-protein
T17	I-Protein	I-Protein	1781	1782	)	)	O	)	I-protein	28	NMOD	I-protein
O	O	O	1783	1792	signaling	signaling	B-NP	NN	O	25	OBJ	O
O	O	O	1792	1793	,	,	O	,	O	7	P	O
O	O	O	1794	1797	and	and	O	CC	O	7	VMOD	O
O	O	O	1798	1801	may	may	B-VP	MD	O	7	VMOD	O
O	O	O	1802	1809	involve	involve	I-VP	VB	O	33	VC	O
O	O	O	1810	1811	a	a	B-NP	DT	O	37	NMOD	O
T27	B-Entity	B-Entity	1812	1820	critical	critical	I-NP	JJ	O	37	NMOD	O
T27	I-Entity	I-Entity	1821	1827	region	region	I-NP	NN	O	34	OBJ	O
T27	I-Entity	I-Entity	1828	1831	for	for	B-PP	IN	O	37	NMOD	O
T18,T27	B-Protein,I-Entity	B-Protein,I-Entity	1832	1835	CD4	CD4	B-NP	NN	B-protein	40	NMOD	B-protein
T27	I-Entity	I-Entity	1836	1848	dimerization	dimerization	I-NP	NN	O	38	PMOD	O
T27	I-Entity	I-Entity	1848	1849	.	.	O	.	O	3	P	O
